mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.43 |
0.007 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.41 |
0.007 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |